Skip to main content
. 1998 Sep 15;95(19):11465–11470. doi: 10.1073/pnas.95.19.11465

Figure 2.

Figure 2

The effect of mAChR antagonists on the CCh-induced potentiation of NMDA-receptor currents. Data presented show the effect of CCh (10 μM) on peak NMDAR currents in the absence of antagonists (Control) or in the presence of the nonspecific mAChR antagonist atropine (1 μM), the m1-selective antagonist pirenzepine (75nM), or the m4-selective antagonist PD 102807 (250 nM). Data are presented as percentage of potentiation (mean ± SEM) of NMDAR current (∗, P < 0.05; n = 5 for each condition).